United Natural Foods Inc: Form 10-Q for the period ended Jan 27, 2024
Filed with the SEC on Mar 6, 2024 and accepted by EDGAR at Mar 6, 2024, 16:35 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-01-27. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-10-29 to 2024-01-27 | $7.78bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-07-30 to 2024-01-27 | $15.33bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-10-29 to 2024-01-27 | $6.74bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-07-30 to 2024-01-27 | $13.26bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-10-29 to 2024-01-27 | $1.03bn | us-gaap:GrossProfit |
| Gross profit | 6 months2023-07-30 to 2024-01-27 | $2.06bn | us-gaap:GrossProfit |
| Operating income | 3 months2023-10-29 to 2024-01-27 | $16.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-07-30 to 2024-01-27 | $0 | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-10-29 to 2024-01-27 | $40.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-07-30 to 2024-01-27 | $75.0m | us-gaap:InterestExpense |
| Income tax | 3 months2023-10-29 to 2024-01-27 | −$5.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-07-30 to 2024-01-27 | −$14.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-10-29 to 2024-01-27 | −$15.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-07-30 to 2024-01-27 | −$54.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-10-29 to 2024-01-27 | −$0.25 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-07-30 to 2024-01-27 | −$0.92 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-29 to 2024-01-27 | −$0.25 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-07-30 to 2024-01-27 | −$0.92 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-10-29 to 2024-01-27 | 59,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-07-30 to 2024-01-27 | 59,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-07-30 to 2024-01-27 | −$71.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-10-29 to 2024-01-27 | $67.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months2023-07-30 to 2024-01-27 | $141.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2023-07-30 to 2024-01-27 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-01-27 | $34.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-01-27 | $3.58bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-01-27 | $7.67bn | us-gaap:Assets |
| Current liabilities | At period end2024-01-27 | $2.34bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-01-27 | $5.98bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-01-27 | $2.18bn | us-gaap:LongTermDebt |
| Current portion of debt | At period end2024-01-27 | $4.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-01-27 | $1.69bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001020859-24-000006. Last ingested by Listed: Nov 4, 2026, 07:56 ET. Listed shows no prices and gives no investment advice.